Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1981 1
1983 1
1984 4
1985 3
1987 2
1988 2
1989 1
1990 2
1992 2
1993 4
1994 4
1995 5
1996 8
1997 4
1998 5
1999 9
2000 6
2001 6
2002 4
2003 4
2004 3
2005 2
2006 2
2008 3
2009 5
2010 6
2011 7
2012 6
2013 4
2014 5
2015 3
2016 2
2017 1
2018 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

121 results

Results by year

Filters applied: . Clear all
Page 1
Untangling the ErbB signalling network.
Yarden Y, Sliwkowski MX. Yarden Y, et al. Among authors: sliwkowski mx. Nat Rev Mol Cell Biol. 2001 Feb;2(2):127-37. doi: 10.1038/35052073. Nat Rev Mol Cell Biol. 2001. PMID: 11252954 Review.
Targeting HER2-positive breast cancer with trastuzumab-DM1, an antibody-cytotoxic drug conjugate.
Lewis Phillips GD, Li G, Dugger DL, Crocker LM, Parsons KL, Mai E, Blättler WA, Lambert JM, Chari RV, Lutz RJ, Wong WL, Jacobson FS, Koeppen H, Schwall RH, Kenkare-Mitra SR, Spencer SD, Sliwkowski MX. Lewis Phillips GD, et al. Among authors: sliwkowski mx. Cancer Res. 2008 Nov 15;68(22):9280-90. doi: 10.1158/0008-5472.CAN-08-1776. Cancer Res. 2008. PMID: 19010901
Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index.
Junutula JR, Raab H, Clark S, Bhakta S, Leipold DD, Weir S, Chen Y, Simpson M, Tsai SP, Dennis MS, Lu Y, Meng YG, Ng C, Yang J, Lee CC, Duenas E, Gorrell J, Katta V, Kim A, McDorman K, Flagella K, Venook R, Ross S, Spencer SD, Lee Wong W, Lowman HB, Vandlen R, Sliwkowski MX, Scheller RH, Polakis P, Mallet W. Junutula JR, et al. Among authors: sliwkowski mx. Nat Biotechnol. 2008 Aug;26(8):925-32. doi: 10.1038/nbt.1480. Epub 2008 Jul 20. Nat Biotechnol. 2008. PMID: 18641636
Antibody therapeutics in cancer.
Sliwkowski MX, Mellman I. Sliwkowski MX, et al. Science. 2013 Sep 13;341(6151):1192-8. doi: 10.1126/science.1241145. Science. 2013. PMID: 24031011 Review.
The HER2-directed antibody-drug conjugate DHES0815A in advanced and/or metastatic breast cancer: preclinical characterization and phase 1 trial results.
Lewis GD, Li G, Guo J, Yu SF, Fields CT, Lee G, Zhang D, Dragovich PS, Pillow T, Wei B, Sadowsky J, Leipold D, Wilson T, Kamath A, Mamounas M, Lee MV, Saad O, Choeurng V, Ungewickell A, Monemi S, Crocker L, Kalinsky K, Modi S, Jung KH, Hamilton E, LoRusso P, Krop I, Schutten MM, Commerford R, Sliwkowski MX, Cho E. Lewis GD, et al. Among authors: sliwkowski mx. Nat Commun. 2024 Jan 11;15(1):466. doi: 10.1038/s41467-023-44533-z. Nat Commun. 2024. PMID: 38212321 Free PMC article. Clinical Trial.
Development of herceptin.
Carter P, Fendly BM, Lewis GD, Sliwkowski MX. Carter P, et al. Among authors: sliwkowski mx. Breast Dis. 2000;11:103-11. doi: 10.3233/bd-1999-11109. Breast Dis. 2000. PMID: 15687596 No abstract available.
Ready to partner.
Sliwkowski MX. Sliwkowski MX. Nat Struct Biol. 2003 Mar;10(3):158-9. doi: 10.1038/nsb0303-158. Nat Struct Biol. 2003. PMID: 12605220 No abstract available.
Preclinical studies with Erlotinib (Tarceva).
Akita RW, Sliwkowski MX. Akita RW, et al. Among authors: sliwkowski mx. Semin Oncol. 2003 Jun;30(3 Suppl 7):15-24. Semin Oncol. 2003. PMID: 12840797 Review.
Perspectives on anti-HER monoclonal antibodies.
Ranson M, Sliwkowski MX. Ranson M, et al. Among authors: sliwkowski mx. Oncology. 2002;63 Suppl 1:17-24. doi: 10.1159/000066203. Oncology. 2002. PMID: 12422051 Review.
121 results